NASDAQ · PDEX
Healthcare · Medical - Instruments & Supplies
$58.16
Down-$3.44 (-5.58%)
Updated Nov 2, 2026, 6:00 AM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · PDEX
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
PDEX closed at $58.16 after 20 trading sessions, down 11.08% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $63.145 | $65.65 | $57.62 | $58.16 | 38.49K |
| Oct 29, 2026 | $64.57 | $65.275 | $61.01 | $61.60 | 43.1K |
| Oct 28, 2026 | $62.01 | $63.63 | $61.72 | $63.19 | 49.5K |
| Oct 27, 2026 | $60.74 | $62.88 | $60.60 | $62.27 | 41.73K |
| Oct 26, 2026 | $62.77 | $62.94 | $60.66 | $60.66 | 52.12K |
| Oct 23, 2026 | $61.83 | $62.72 | $60.635 | $62.22 | 54.29K |
| Oct 22, 2026 | $60.30 | $63.2399 | $60.30 | $62.38 | 24.84K |
| Oct 21, 2026 | $59.76 | $60.715 | $59.60 | $60.56 | 20.59K |
| Oct 20, 2026 | $57.66 | $60.2098 | $57.66 | $59.395 | 23.18K |
| Oct 19, 2026 | $58.44 | $58.80 | $56.00 | $57.70 | 34.05K |
| Oct 16, 2026 | $59.89 | $59.89 | $58.16 | $58.26 | 23.89K |
| Oct 15, 2026 | $59.61 | $60.99 | $59.15 | $60.02 | 31.87K |
| Oct 14, 2026 | $61.88 | $62.75 | $59.565 | $59.82 | 61.52K |
| Oct 13, 2026 | $62.85 | $63.115 | $61.95 | $62.27 | 29.09K |
| Oct 12, 2026 | $62.30 | $63.97 | $61.995 | $63.09 | 66.54K |
| Oct 9, 2026 | $63.05 | $63.725 | $61.80 | $62.49 | 31.87K |
| Oct 8, 2026 | $63.16 | $63.80 | $60.54 | $62.21 | 54.93K |
| Oct 7, 2026 | $64.03 | $64.75 | $62.345 | $62.80 | 53.6K |
| Oct 6, 2026 | $65.04 | $66.85 | $64.03 | $64.92 | 74.13K |
| Oct 5, 2026 | $63.98 | $66.9999 | $63.45 | $65.405 | 45.15K |
The latest Smart Investors Daily articles mentioning PDEX.
Company
Market Activity
Research & News
PDEX research
Company profile and research snapshot.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 11, 2026 | Ascendiant Capital | Buy | — |
| May 12, 2026 | Ascendiant Capital | Buy | — |
| May 27, 2025 | Ascendiant Capital | Buy | — |
| Nov 11, 2024 | Ascendiant Capital | Buy | — |
| Sep 9, 2024 | Ascendiant Capital | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 2, 2026
Medical-dental supplies see durable demand from specialty care, AI and aging trends, with McKesson and peers navigating tariffs and inflation.
Yahoo · Oct 1, 2026
Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.
Yahoo · Sep 18, 2026
PDEX, APH and RELY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 18th, 2026.
Benzinga · Sep 11, 2026
Ascendiant Capital analyst Edward Woo maintains Pro-Dex (NASDAQ:PDEX) with a Buy and raises the price target from $70 to $74.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning PDEX.
